Delivery Order SPE2DB25D3404-SPE2DB25FUPLV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,045.99 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for June 2, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of the vendor's pharmaceutical supply relationship with DLA's medical procurement operations. The award falls...
- The Defense Logistics Agency awarded a delivery order valued at $33,875.59 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, effective through September 5, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor vehicle running...
- The Defense Logistics Agency has awarded a delivery order valued at approximately $30k to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of June 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $138,315.26 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $13,905.99 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $4,626.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $41,292.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of July 31, 2025. This non-competitive delivery order was issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. The award represents a routine pharmaceutical procurement supporting federal medical supply needs within the defense healthcare system....
- The Defense Logistics Agency awarded a delivery order valued at approximately $31.2K to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania. This award was made on August 19, 2025, under a firm fixed-price delivery order contract with an ultimate completion date of August 20, 2025. The contract utilized no set-aside designation, indicating the award resulted from open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $12,919.20 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $11,857.96 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with performance completed in Conshohocken, Pennsylvania. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilized firm fixed-price pricing under a non-competitive set-aside arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPLVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $33,133.86 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for July 29, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle active through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, specialty drugs, vaccines, and medical devices. The company's demonstrated capability to meet federal requirements through open competition positions it as a key provider for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award supports military and veteran healthcare supply chains through delivery of Enbrel, a specialty immunosuppressant medication commonly prescribed for rheumatoid arthritis and other autoimmune conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.1k | 7/28/25 |